tiprankstipranks
Advertisement

EDOW - ETF AI Analysis

Compare

Top Page

EDOW

First Trust Dow 30 Equal Weight ETF (EDOW)

Rating:73Outperform
Price Target:
EDOW’s rating reflects a solid, diversified mix of blue-chip stocks, led by strong contributors like Microsoft, Merck, Salesforce, and Nvidia, which all benefit from robust financial performance, growth in areas like cloud, AI, and healthcare, and generally positive earnings outlooks. The fund’s score is held back somewhat by weaker names such as 3M and Sherwin-Williams, where high debt, valuation concerns, and technical weakness introduce more risk. The main risk factor is that many top holdings are priced for high growth, so any slowdown or market shift away from these growth-focused sectors could pressure the ETF’s performance.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past few months, showing positive momentum.
Equal-Weight Exposure to Dow Stocks
Each Dow 30 company is held in similar size, so the fund is not overly dependent on just one or two mega-cap names for returns.
Broad Sector Mix Within the U.S.
Holdings spread across technology, financials, health care, industrials, and consumer sectors help reduce the impact of weakness in any single industry.
Negative Factors
Higher Expense Ratio
The fund’s fee is on the higher side for a large-cap U.S. equity ETF, which can modestly reduce long-term returns.
Pure U.S. Market Focus
Almost all assets are invested in U.S. companies, offering little diversification across other global markets.
Mixed Performance Among Top Holdings
While several major positions have performed strongly, a few have shown weak or negative results, which can dampen overall gains.

EDOW vs. SPDR S&P 500 ETF (SPY)

EDOW Summary

The First Trust Dow 30 Equal Weight ETF (EDOW) tracks the Dow Jones Industrial Average Equal Weight Index, which means it invests in all 30 Dow stocks but gives each one about the same importance. It holds big, well-known U.S. companies like Apple and JPMorgan Chase across many sectors, including technology, finance, health care, and industrials. Someone might invest in EDOW to get diversified exposure to large, established “blue-chip” companies without relying too heavily on any single stock. A key risk is that the ETF can rise or fall with the overall stock market, so its value is not guaranteed.
How much will it cost me?The First Trust Dow 30 Equal Weight ETF (EDOW) has an expense ratio of 0.50%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy to equally weight the Dow 30 stocks, requiring more oversight compared to passively managed funds. It offers a unique approach to diversification, but the higher cost reflects the added management involved.
What would affect this ETF?The First Trust Dow 30 Equal Weight ETF (EDOW) could benefit from positive trends in technology and healthcare sectors, which make up a significant portion of its holdings, especially as innovation and demand in these areas continue to grow. However, economic challenges such as rising interest rates or a slowdown in consumer spending could negatively impact financial and consumer-focused companies within the ETF. Additionally, regulatory changes or geopolitical tensions affecting U.S.-based large-cap companies may influence overall performance.

EDOW Top 10 Holdings

EDOW spreads its bets evenly across the Dow, but a few names are doing the heavy lifting. Health care standouts like Merck and Amgen are rising steadily, giving the fund a solid defensive backbone, while Microsoft and Nvidia keep the tech engine humming despite some mixed signals and lofty expectations. On the softer side, Travelers and Sherwin-Williams have been more hesitant, occasionally tapping the brakes on performance. Overall, this is a U.S.-only, blue-chip mix with a tilt toward technology and financials rather than a single stock calling the shots.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Salesforce4.63%$15.16M$210.69B-0.10%
80
Outperform
Microsoft4.00%$13.08M$3.81T1.35%
79
Outperform
Amgen3.96%$12.96M$233.78B50.30%
77
Outperform
Merck & Company3.85%$12.61M$366.00B76.36%
80
Outperform
Travelers Companies3.77%$12.35M$77.15B36.24%
78
Outperform
Visa3.65%$11.96M$712.47B8.48%
70
Outperform
JPMorgan Chase3.58%$11.71M$950.62B18.64%
72
Outperform
Sherwin-Williams Company3.51%$11.49M$83.72B-5.73%
66
Neutral
Johnson & Johnson3.48%$11.38M$645.95B51.29%
78
Outperform
Amazon3.46%$11.33M$2.87T16.34%
71
Outperform

EDOW Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
45.46
Positive
100DMA
44.24
Positive
200DMA
42.85
Positive
Market Momentum
MACD
0.25
Positive
RSI
54.69
Neutral
STOCH
61.02
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EDOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 46.29, equal to the 50-day MA of 45.46, and equal to the 200-day MA of 42.85, indicating a bullish trend. The MACD of 0.25 indicates Positive momentum. The RSI at 54.69 is Neutral, neither overbought nor oversold. The STOCH value of 61.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EDOW.

EDOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$326.00M0.50%
73
Outperform
$985.62M0.15%
73
Outperform
$981.55M0.19%
72
Outperform
$960.73M0.75%
71
Outperform
$935.23M0.25%
71
Outperform
$894.22M0.09%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EDOW
First Trust Dow 30 Equal Weight ETF
46.34
7.26
18.58%
CVLC
Calvert US Large-Cap Core Responsible Index ETF
IUS
Invesco RAFI Strategic US ETF
FTQI
First Trust Hedged BuyWrite Income ETF
SPHB
Invesco S&P 500 High Beta ETF
PTL
Inspire 500 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement